Activity of eltrombopag in severe aplastic anemia

Since the approval of horse antithymocyte globulin (ATG) decades ago, there was a long hiatus in therapies with activity in severe aplastic anemia (SAA). This scenario changed in 2014 when eltrombopag, a thrombopoietin receptor agonist, was approved for SAA after an insufficient response to initial...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hematology Am Soc Hematol Educ Program
Hovedforfatter: Scheinberg, Phillip
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2018
Fag:
Severe Aplastic Anemia: Diagnosis and Management in an Era of Effective Therapies
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245975/
https://ncbi.nlm.nih.gov/pubmed/30504345
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker